Tapewire

Nasdaq · USD

ELVN

Enliven Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4024
SEC CIK
0001672619
Parsed reports
377

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202503
Jan 2026013
Feb 202603
Mar 202605
Apr 202603
May 202603
Jun 2026015
Jul 2026012
Aug 202605
Sep 202606
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 07, 2025 Filed Jan 10, 2025 22:31 UTC
Patel AnishCHIEF OPERATING OFFICER
Exercise / conversionCommon Stock 2,000 $2.48 $4,960.00
Disclosure

SEC source: 0001415889-25-001301 · form4-01102025_100148.xml · nonDerivative · entry 2

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").

Read SEC document
January 07, 2025 Filed Jan 10, 2025 22:31 UTC
Patel AnishCHIEF OPERATING OFFICER
Exercise / conversionCommon Stock 10,700 $1.12 $11,984.00
Disclosure

SEC source: 0001415889-25-001301 · form4-01102025_100148.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").

Read SEC document
January 03, 2025 Filed Jan 7, 2025 21:43 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-25-001007 · form4-01072025_090141.xml · derivative · entry 5

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,306

Underlying: Common Stock · 1,000 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

F5 · balance_after: The number of derivative securities beneficially owned following the option exercise is as of January 3, 2025 and reflects the option exercise that occurred December 13, 2024, and reported herein, and subsequent option exercises that occurred on December 27, 2024 and December 30, 2024 as reported in a Form 4 filed by the Reporting Person on December 31, 2024

Read SEC document
January 03, 2025 Filed Jan 7, 2025 21:43 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,000 $25.04 $25,038.60
Disclosure

SEC source: 0001415889-25-001007 · form4-01072025_090141.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,000

F1 · kind: The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.045. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 03, 2025 Filed Jan 7, 2025 21:43 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,000 $2.48 $2,480.00
Disclosure

SEC source: 0001415889-25-001007 · form4-01072025_090141.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The 1,000 share option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 30, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 900 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · derivative · entry 6

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,306

Underlying: Common Stock · 900 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 30, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 900 $22.51 $20,255.49
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · nonDerivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $22.50 to $22.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 30, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 900 $2.48 $2,232.00
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 3,350 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · derivative · entry 5

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,206

Underlying: Common Stock · 3,350 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 3,350 $22.15 $74,218.92
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.58 to $22.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 3,350 $2.48 $8,308.00
Disclosure

SEC source: 0001415889-24-030323 · form4-12312024_101209.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 13, 2024 Filed Jan 7, 2025 21:43 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 13,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-25-001007 · form4-01072025_090141.xml · derivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,556

Underlying: Common Stock · 13,000 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

F4 · balance_after: The number of derivative securities beneficially owned following the option exercise was as of December 13, 2024 and does not reflect subsequent option exercises that occurred on December 27, 2024 and December 30, 2024 as reported in a Form 4 filed by the Reporting Person on December 31, 2024.

Read SEC document
December 13, 2024 Filed Jan 7, 2025 21:43 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 13,000 $2.48 $32,240.00
Disclosure

SEC source: 0001415889-25-001007 · form4-01072025_090141.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 5,250 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-028001 · form4-12022024_101235.xml · derivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,556

Underlying: Common Stock · 5,250 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,000 $25.38 $25,375.50
Disclosure

SEC source: 0001415889-24-028001 · form4-12022024_101235.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $25.26 to $25.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 4,250 $24.78 $105,312.88
Disclosure

SEC source: 0001415889-24-028001 · form4-12022024_101235.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,000

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $24.25 to $25.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
November 27, 2024 Filed Dec 2, 2024 22:18 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 5,250 $2.48 $13,020.00
Disclosure

SEC source: 0001415889-24-028001 · form4-12022024_101235.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
October 28, 2024 Filed Oct 30, 2024 22:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 6,250 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-025779 · form4-10302024_101039.xml · derivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,806

Underlying: Common Stock · 6,250 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 28, 2024 Filed Oct 30, 2024 22:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 650 $29.11 $18,922.15
Disclosure

SEC source: 0001415889-24-025779 · form4-10302024_101039.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $28.97 to $29.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 28, 2024 Filed Oct 30, 2024 22:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 5,600 $28.49 $159,562.48
Disclosure

SEC source: 0001415889-24-025779 · form4-10302024_101039.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 650

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $27.97 to $28.96. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 28, 2024 Filed Oct 30, 2024 22:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 6,250 $2.48 $15,500.00
Disclosure

SEC source: 0001415889-24-025779 · form4-10302024_101039.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 16:22 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 847 $30.00 $25,412.54
Disclosure

SEC source: 0001415889-24-025504 · form4-10222024_081010.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,015,188

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 16:21 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 924 $30.00 $27,722.68
Disclosure

SEC source: 0001415889-24-025503 · form4-10222024_081007.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,002,892

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:23 UTC
Patel AnishCHIEF OPERATING OFFICER
SaleCommon Stock 716 $30.00 $21,482.51
Disclosure

SEC source: 0001415889-24-025505 · form4-10222024_081006.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 343,311

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Patel / Dong Family Trust Dated August 24 2017 for which the Reporting Person serves as trustee.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:19 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 814 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-025501 · form4-10222024_081055.xml · derivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,056

Underlying: Common Stock · 814 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:19 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 814 $30.00 $24,422.44
Disclosure

SEC source: 0001415889-24-025501 · form4-10222024_081055.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:19 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 814 $2.48 $2,018.72
Disclosure

SEC source: 0001415889-24-025501 · form4-10222024_081055.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:18 UTC SaleCommon Stock 753 $30.00 $22,591.58
Disclosure

SEC source: 0001415889-24-025500 · form4-10222024_081053.xml · nonDerivative · entry 2

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 27,165

F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person and by RAHD Capital LLC on July 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:18 UTC SaleCommon Stock 817 $30.00 $24,512.45
Disclosure

SEC source: 0001415889-24-025500 · form4-10222024_081053.xml · nonDerivative · entry 1

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,673

F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person and by RAHD Capital LLC on July 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:17 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 816 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-025499 · form4-10222024_081038.xml · derivative · entry 3

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,268

Underlying: Common Stock · 816 shares

Expires 2031-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · derivative.exercise_date: The option, originally for 287,084 shares, vested as to one-fourth of the shares on June 17, 2022, and the remainder vest in 36 equal monthly installments thereafter.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:17 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
SaleCommon Stock 816 $30.00 $24,482.45
Disclosure

SEC source: 0001415889-24-025499 · form4-10222024_081038.xml · nonDerivative · entry 2

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 18, 2024 Filed Oct 22, 2024 20:17 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
Exercise / conversionCommon Stock 816 $2.48 $2,023.68
Disclosure

SEC source: 0001415889-24-025499 · form4-10222024_081038.xml · nonDerivative · entry 1

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 21:06 UTC SaleCommon Stock 1,270 $27.67 $35,143.31
Disclosure

SEC source: 0001415889-24-025381 · form4-10172024_091039.xml · nonDerivative · entry 1

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,490

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $27.1521 to $27.9631. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 09, 2024 Filed Oct 10, 2024 20:39 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 3,589 $28.52 $102,357.92
Disclosure

SEC source: 0001415889-24-024992 · form4-10112024_121044.xml · nonDerivative · entry 4

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,016,035

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $28.50 to $28.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 09, 2024 Filed Oct 10, 2024 20:39 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 34,289 $28.12 $964,203.25
Disclosure

SEC source: 0001415889-24-024992 · form4-10112024_121044.xml · nonDerivative · entry 3

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,019,624

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $28.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 09, 2024 Filed Oct 10, 2024 20:38 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 2,830 $28.53 $80,729.71
Disclosure

SEC source: 0001415889-24-024991 · form4-10112024_121018.xml · nonDerivative · entry 4

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,003,816

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $28.51to $28.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 09, 2024 Filed Oct 10, 2024 20:38 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 13,880 $28.07 $389,675.45
Disclosure

SEC source: 0001415889-24-024991 · form4-10112024_121018.xml · nonDerivative · entry 3

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,006,646

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $28.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 08, 2024 Filed Oct 10, 2024 20:39 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 100 $28.51 $2,851.00
Disclosure

SEC source: 0001415889-24-024992 · form4-10112024_121044.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,053,913

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 08, 2024 Filed Oct 10, 2024 20:39 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 13,167 $27.96 $368,173.02
Disclosure

SEC source: 0001415889-24-024992 · form4-10112024_121044.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,054,013

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 08, 2024 Filed Oct 10, 2024 20:38 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 100 $28.51 $2,851.00
Disclosure

SEC source: 0001415889-24-024991 · form4-10112024_121018.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,020,526

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 08, 2024 Filed Oct 10, 2024 20:38 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 13,167 $27.95 $368,078.22
Disclosure

SEC source: 0001415889-24-024991 · form4-10112024_121018.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,020,626

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 08, 2024 Filed Oct 11, 2024 00:36 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,106 $0.00 Strike: $5.52 $0.00
Disclosure

SEC source: 0001415889-24-024990 · form4-10112024_121018.xml · derivative · entry 5

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,322

Underlying: Common Stock · 4,106 shares

Expires 2032-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F4 · derivative.exercise_date: The option, originally for 32,849 shares, vested as to one-fourth of the shares on January 28, 2023, and the remainder of the shares vest in 12 equal quarterly installments thereafter.

Read SEC document
October 08, 2024 Filed Oct 11, 2024 00:36 UTC Exercise / conversionStock Option (right to buy) · Derivative 6,314 $0.00 Strike: $19.68 $0.00
Disclosure

SEC source: 0001415889-24-024990 · form4-10112024_121018.xml · derivative · entry 4

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,428

Underlying: Common Stock · 6,314 shares

Expires 2029-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Read SEC document
October 08, 2024 Filed Oct 11, 2024 00:36 UTC SaleCommon Stock 10,420 $28.17 $293,557.45
Disclosure

SEC source: 0001415889-24-024990 · form4-10112024_121018.xml · nonDerivative · entry 3

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,341

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $28.00 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
October 08, 2024 Filed Oct 11, 2024 00:36 UTC Exercise / conversionCommon Stock 4,106 $5.52 $22,665.12
Disclosure

SEC source: 0001415889-24-024990 · form4-10112024_121018.xml · nonDerivative · entry 2

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
October 08, 2024 Filed Oct 11, 2024 00:36 UTC Exercise / conversionCommon Stock 6,314 $19.68 $124,259.52
Disclosure

SEC source: 0001415889-24-024990 · form4-10112024_121018.xml · nonDerivative · entry 1

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 18:58 UTC
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
SaleCommon Stock 2,707 $27.61 $74,727.01
Disclosure

SEC source: 0001415889-24-024902 · form4-10082024_101021.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,067,180

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $27.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · ownership.nature: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 18:57 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 2,730 $27.50 $75,075.00
Disclosure

SEC source: 0001415889-24-024901 · form4-10082024_101015.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,033,793

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · ownership.nature: The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 22:56 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 1,270 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-024900 · form4-10082024_101002.xml · derivative · entry 6

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,870

Underlying: Common Stock · 1,270 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 22:56 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,270 $27.51 $34,935.29
Disclosure

SEC source: 0001415889-24-024900 · form4-10082024_101002.xml · nonDerivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $27.50 to $27.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.